Thesis Times

Markets & Economy·Feb 20

Exact Sciences Shareholders Vote 99% in Favor of Abbott Acquisition

With shareholder approval secured, EXAS is on track to exit independent trading before year-end - here's what the deal means for diagnostic sector positioning.

EXAS · ABT